US nonfarm payrolls increased by a seasonally adjusted 199,000 ... The biggest jobs gains came from the healthcare sector (77,000), government (49,000), manufacturing (28,000), and leisure and ...
ASSASSINATED: Malcolm X was shot dead on 21 February 1965 in Upper Manhattan (Image: via Getty Images) ONE OF the men who was cleared of killing Malcolm X is suing the US government claiming the ...
Merck (NYSE:MRK) announced on Tuesday a deal to acquire Caraway Therapeutics for up to $610M. The potential consideration includes an undisclosed upfront payment and contingent milestone payments.
United States government agencies spent months, sometimes years, investigating Binance in the lead-up to unsealing an indictment against the exchange. Binance and its founder, Changpeng “CZ ...
A version of this story appeared in CNN’s What Matters newsletter. To get it in your inbox, sign up for free here. Condemning Elon Musk is easy. Quitting him would be very hard, especially for ...
Condemning Elon Musk is easy. Quitting him would be very hard, especially for the US government, which is stuck in a needy relationship with the billionaire who went from endorsing crackpot ...
The civil rights law, which outlaws racial discrimination as it relates to voting, has typically been enforced by lawsuits from these groups, not by the government ... to the US supreme court.
The government needs for electric vehicles to access his network of chargers. Officials need his social media platform – Twitter, now called X – to communicate with people.
Nov 17 (Reuters) - Advisers to the U.S. health regulator said on Friday that data on Merck's (MRK.N) chronic cough drug does not provide sufficient evidence to prove its clinical benefit for patients.
(Reuters) - The U.S. health regulator's advisers said on Friday that data on Merck's chronic cough drug gefapixant does not provide sufficient evidence to prove its clinical benefit for patients.
Nov 17 (Reuters) - The U.S. health regulator's advisers said on Friday that data on Merck's MRK.N chronic cough drug gefapixant does not provide sufficient evidence to prove its clinical benefit ...
FDA Panel Flags Insufficient Data for Merck's Chronic Cough Drug By Khushi Mandowara and Christy Santhosh (Reuters) -Advisers to the U.S. health regulator said on Friday that data on Merck's ...
